Therapy With Agents Acting on the Renin-Angiotensin System and Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection

Clin Infect Dis. 2020 Nov 19;71(16):2291-2293. doi: 10.1093/cid/ciaa634.

Abstract

Exposure to agents acting on the renin-angiotensin system was not associated with a risk increase of COVID-19 infection in 2 Italian matched case-control studies, 1 nested in hypertensive patients and the other in patients with cardiovascular diseases or diabetes.

Keywords: ACE inhibitors; COVID-19; SARS-CoV-2; administrative data; angiotensin II receptor blockers.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiotensin Receptor Antagonists / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • COVID-19 / complications*
  • COVID-19 / physiopathology
  • Cardiovascular Diseases / complications
  • Case-Control Studies
  • Cohort Studies
  • Diabetes Complications
  • Female
  • Humans
  • Hypertension / complications
  • Italy
  • Male
  • Middle Aged
  • Renin-Angiotensin System / drug effects*
  • Risk Factors
  • SARS-CoV-2
  • Severity of Illness Index*

Substances

  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors